A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041) | MicrobiomeTrials
A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-11-26Est. Completion: 2030-01-08
Enrollment target: 352 participants
Other microbiome trials you might be interested in